Home > Insider Trading > Filing (0001179110-22-000394)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070081	Ptc Therapeutics Inc.	PTCT	Pharmaceutical Preparations (2834)	043416587

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1578962	Walter Stuart Peltz	C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-01-07	1,869	$38.53	78,446	No	4	S	Direct
Common Stock	Acquisiton	2022-01-07	44,000	$0.00	122,446	No	4	A	Direct
Common Stock	Disposition	2022-01-07	294	$38.53	22,540	No	4	S	Indirect	By Spouse
Common Stock	Acquisiton	2022-01-07	16,800	$0.00	39,340	No	4	A	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct
No	4	S	Indirect	By Spouse
No	4	A	Indirect	By Spouse

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2022-01-07	165,000	$0.00	165,000	$38.10
Common Stock	Stock Option (Right to Buy)	Acquisiton	2022-01-07	63,000	$0.00	63,000	$38.10

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
165,000		2032-01-06	No	4	A	Direct
63,000		2032-01-06	No	4	A	Indirect

Footnotes

Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 6,900 RSUs from a January 6, 2021 grant of 27,600 RSUs.
Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023.
Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 990 RSUs from a January 6, 2021 grant of 3,960 RSUs.
This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.